TB-500 for Tendon & Ligament Repair: What the Research Shows

TB-500 (Thymosin Beta-4) promotes tendon and ligament healing through cell migration, angiogenesis, and inflammation reduction. Learn the research-backed loading protocol (2-2.5mg 2x/week), injection method, and recovery timeline.

N

Novo Pharma Research Team

Novo Pharma Research · peer-reviewed literature synthesis

16 min read
TB-500 peptideTB-500 tendon repairthymosin beta 4TB-500 healingTB-500 dosage

TB-500 for Tendon & Ligament Repair: What the Research Shows

References:

  1. Goldstein AL, et al. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-429. PMID: 16099219
  2. Philp D, et al. Thymosin beta 4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev. 2004;125(2):113-115. PMID: 15037011
  3. Smart N, et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature. 2007;445(7124):177-182. PMID: 17108969
  4. Sosne G, et al. Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res. 2002;74(2):293-299. PMID: 11950239
  5. Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. PMID: 10469334
  6. Ehrlich HP, Bhagavan NV. The effect of thymosin beta-4 on cell composition and collagen in carrageenan-induced granuloma pouches. Proc Soc Exp Biol Med. 1991;196(3):300-304. PMID: 1998007
  7. Dowling BA, et al. Recombinant equine growth hormone does not affect biomechanical properties of the superficial digital flexor tendon in standardbred horses in training. Vet Surg. 2002;31(1):61-66. PMID: 11778169
  8. Ruff D, et al. Thymosin Beta-4 for the treatment of non-healing venous stasis ulcers: results of a Phase II study. J Invest Dermatol. 2010;130:S82.
  9. Treadwell T, et al. The regenerative properties of thymosin β4 in the treatment of sports injuries and wound care. Expert Opin Biol Ther. 2018;18(sup1):131-138. PMID: 30063872
  10. Kleinman HK, Sosne G. Thymosin beta 4 and the potential for use in cancer therapy. Ann N Y Acad Sci. 2016;1374(1):96-102. PMID: 27333077

This article is for educational purposes only and does not constitute medical advice. Consult a healthcare professional before using any research compound.

Research chemical disclaimer

All compounds discussed and sold through Novo Pharma are intended strictly for laboratory and in-vitro research purposes. Products are not for human or animal consumption, not for use in food, cosmetics, or medicinal applications, and not for any therapeutic or diagnostic use.

The information on this page is provided for educational context and documents findings from published research. It is not medical advice, not a recommendation, and not a suggestion that any compound be used outside of a controlled research environment. Consult a qualified healthcare professional for any medical or health-related decision.

By purchasing, you confirm you are a qualified researcher, accept full responsibility for proper handling and disposal, and agree to use compounds in compliance with all applicable local, provincial, and federal laws.